Archive

Ivermectin for covid-19 – the highlights

Written by | 29 Jul 2023

Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for […]

The SAIVE trial for prevention of COVID-19

Written by | 8 Feb 2023

Professor Colleen Aldous is a research professor at in the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial […]

How the totality of evidence for ivermectin informs clinical practice

Written by | 7 Feb 2023

Colleen Aldous, Professor for Medical Research, University of KwaZulu-Natal explains how the evidence supporting the use of ivermectin for covid-19 came together to tell a compelling story. In […]

Addressing the totality of evidence for ivermectin

Written by | 6 Feb 2023

When assessing repurposed drugs in a pandemic situation, the totality of evidence should be considered rather than RCTs alone; had this been done the pandemic could have been […]

TOGETHER trial shows positive effect for ivermectin

Written by | 5 Feb 2023

The TOGETHER trial was widely reported as showing that ivermectin was not effective in covid-19, but a straightforward analysis of the results reveals a 59 per cent reduction […]

Ivermectin – is it safe and effective?

Written by | 4 Feb 2023

The best time to administer ivermectin is at the beginning of a covid-19 infection so that virus is killed and disease progression averted, according to Colleen Aldous, Professor […]

What makes the SAIVE study so good?

Written by | 3 Feb 2023

Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of […]

Real world evidence from Peru and Colombia confirms ivermectin safe and effective

Written by | 27 Mar 2021

The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and effectiveness of ivermectin, according to Dr […]

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin, according to Dr David Scheim. https://www.youtube.com/watch?v=T67szXgTqWw&ab_channel=MedicalUpdateOnline […]

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent controlled trial of ivermectin for covid-19 […]

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]

Analysis confirms 14 fold reduction in deaths with Ivermectin treatment in Peru

Written by | 23 Mar 2021

Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.